Not
all back pain is the same
In
the last 10 years, much progress has been made in defining chronic low back
pain (CLBP). CLBP is defined as back
pain > 3 months duration. There are 2 different types of CLBP, namely
inflammatory and mechanical back pain. This takes into account the exclusion of
CLBP with red flags or sinister features. Inflammatory back pain (IBP) is known
to be a presenting feature of ankylosing spondylitis (AS). AS is a chronic
inflammatory arthritis with predominant involvement of the spine resulting in
inflammation of joints, in particular the sacroiliac (SI) joints.
I
wanted to take some time to appreciate the papers from the beginning of the
last decade (from 2004) which has highlighted the features and use of IBP
identification. IBP is part of the new classification of the
spondyloarthritides (SPA) by the Assessment of SpondyloArthritis International
Society (ASAS)1. SPA is a group of
inflammatory conditions with AS being the characteristic clinical condition.
On average it takes 8.5 years for the diagnosis of AS to
be made. It is important that patients with IBP are detected early and referred
for further investigation and treatment. IBP is the leading symptom for axial
SPA and is present in 70% of patients with SPA2. The features of IBP
are 3,4.
Inflammatory back pain (if 4 out of 5 features are
present)5
|
|
SPA
affecting the spine (axial SPA) is present in 5% of patients with CLBP6. If IBP is present, the likelihood of axial SPA
goes up from 5% to 14%. On the other hand, if IBP is absent, the likelihood of
axial SPA falls to less than 2%7. This is an
important point as IBP alone is not enough to make a diagnosis of axial SPA. To
reach a high enough probability of axial SPA (that is > 90%), other clinical
features are needed 8.
The
features of axial SpA that should be identified include clinical features,
laboratory tests (eg. HLA-B27) and radiological imaging (eg. MRI). The clinical
features that may point towards axial SPA include a good response to NSAIDs
within 48 hours, uveitis, family history and peripheral arthritis9,10. When patients have
IBP, the presence of 3 or more features of SPA increases the likelihood of definite
axial SPA (80-95%). If 1 or 2 additional features of SPA are present, then the
likelihood of axial SPA is lower between 35-70%7, 11. When IBP, clinical,
laboratory and radiological factors are brought together, the sum of the
presence of each factor can be calculated to give the probability of definite
axial SPA12. This will mean a
better and quicker way to make a diagnosis of axial SPA and better outcome for
patients.
The
identification of IBP in patients presenting to their general practitioners
(GPs) in primary care with CLBP is the first step towards further assessment
and investigations of axial SPA. Education of GPs and physiotherapists who see
patients in primary care is important. On the 29th May 2014, I ran a
Back Pain Seminar in Reading which was attended by over 70 GPs and
physiotherapist. The focus was on the importance of identifying IBP in patients
with CLBP. Patients with IBP can then be assessed for any clinical features
associated with SPA and referred for any relevant investigations. This will
help reduce the delay in diagnosing axial SpA and ankylosing spondylitis.
The Faculty (L-R): Berit Sund (organiser), Sally Dickinson, Claire Harris, Dr. Antoni Chan, Susan Hicks, Claire Jeffries |
Sally Dickinson from the National Ankylosing Spondylitis Society (NASS) giving an update on the role of NASS |
References
1. Sieper J, Rudwaleit M, Baraliakos X, et
al. The Assessment of SpondyloArthritis international Society (ASAS) handbook:
a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl
2:ii1-44. doi:10.1136/ard.2008.104018.
2. Dougados
M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study
Group Preliminary Criteria for the Classification of Spondylarthropathy.;
1991:1218-1227. doi:10.1002/art.1780341003.
3. Rudwaleit
M, van der Heijde D, Landewé R, et al. The development of Assessment of
SpondyloArthritis international Society classification criteria for axial
spondyloarthritis (part II): validation and final selection. Ann Rheum Dis.
2009;68(6):777-83. doi:10.1136/ard.2009.108233.
4. Rudwaleit
M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing
spondylitis: a reassessment of the clinical history for application as
classification and diagnostic criteria. Arthritis Rheum.
2006;54(2):569-78. doi:10.1002/art.21619.
5. Sieper
J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain
in patients with chronic back pain: a real patient exercise by experts from the
Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis.
2009;68(6):784-8. doi:10.1136/ard.2008.101501.
6. Underwood
MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol.
1995;34(11):1074-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8542211.
7. Rudwaleit
M, van der Heijde D, Khan M a, Braun J, Sieper J. How to diagnose axial
spondyloarthritis early. Ann Rheum Dis. 2004;63(5):535-43.
doi:10.1136/ard.2003.011247.
8. Rudwaleit
M, Khan M a, Sieper J. The challenge of diagnosis and classification in early
ankylosing spondylitis: do we need new criteria? Arthritis Rheum.
2005;52(4):1000-8. doi:10.1002/art.20990.
9. Sieper
J, Rudwaleit M. Early referral recommendations for ankylosing spondylitis
(including pre-radiographic and radiographic forms) in primary care. Ann
Rheum Dis. 2005;64(5):659-63. doi:10.1136/ard.2004.028753.
10. Rudwaleit
M, Sieper J. Referral strategies for early diagnosis of axial
spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):262-8.
doi:10.1038/nrrheum.2012.39.
11. Brandt
HC, Spiller I, Song I-H, Vahldiek JL, Rudwaleit M, Sieper J. Performance of referral
recommendations in patients with chronic back pain and suspected axial
spondyloarthritis. Ann Rheum Dis. 2007;66(11):1479-84.
doi:10.1136/ard.2006.068734.
12. Feldtkeller
E, Rudwaleit M, Zeidler H. Easy probability estimation of the diagnosis of early
axial spondyloarthritis by summing up scores. Rheumatology (Oxford).
2013;52(9):1648-50. doi:10.1093/rheumatology/ket176.
@synovialjoints
Views are my
own. These are opinions and cannot replace the need to see your physician for
review of your individual medical condition.
No comments:
Post a Comment